The safety and efficacy of chemotherapy combined with immunotherapy for pancreatic cancer: A meta-analysis

Yang Huang, Xu Yan, Tian Ren, Fan Yi, Qi Li, Chunyang Zhang
2021-07-23
Abstract:Background:Since the combination of chemotherapy and immunotherapy, such as new molecular targeted drugs or vaccines, is controversial in terms of survival advantages compared with chemotherapy therapy alone, we conducted a meta-analysis to compare the efficacy and safety of immunotherapy combined with chemotherapy and chemotherapy alone for advanced pancreatic cancer.Methods:We searched PubMed, Embase, and Cochrane Library from the establishment of the database to November 2020. We included some studies that reported pancreatic cancer patients receiving immunotherapy, and we excluded duplicate publications, research without full text, incomplete information or inability to conduct data extraction, animal experiments, reviews, and systematic reviews.Results:The risk ratio of the objective response rate and disease control rate was 1.10 (95% confidence interval [CI]: 0.88–1.38) and …
What problem does this paper attempt to address?